Companies: 10,795·Total market cap: $144.5T
Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V.

GNMLFOTCHealthcare● Active
$0.95
$-0.13(-12.04%)
Market Cap$928865018
P/E Ratio
52W High$1.17
52W Low$0.91
Overview

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GNMLF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$1.31gnmlf eps ttm · gnmlf earnings per shareEarnings history
PE Ratio (TTM)0.7×gnmlf pe ratio ttm · gnmlf price to earningsPE Ratio deep dive
Revenue (TTM)$12.9Bgnmlf revenue ttm · gnmlf annual revenueFull revenue history
Dividend Yield4.79%does gnmlf pay dividends · gnmlf dividend yieldDividend history
Shares Outstanding974.2Mgnmlf shares outstanding · gnmlf floatShares outstanding history
Next EarningsJul 22, 2026Est.gnmlf earnings date · gnmlf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$17.52B▼ 5.83% YoY
202320242025
genomma lab internacional, s.a.b. de c.v. revenue · gnmlf revenue 2025
FY 2025Net Income$1.61B▲ +7.54% YoY
202320242025
genomma lab internacional, s.a.b. de c.v. net income · gnmlf profit 2025
FY 2025EPS$1.65▲ +7.84% YoY
202320242025
gnmlf eps · genomma lab internacional, s.a.b. de c.v. earnings per share 2025
TTM:Revenue: $12.90BNet Income: $1.27BEPS: $1.31View income statement →

Stock Performance

Full History
1D-12.04%
1W-12.04%
1M-12.04%
3M-5.00%
YTD-10.38%
1Y-16.67%
5Y-5.00%

About Genomma Lab Internacional, S.A.B. de C.V.

CEOJuan Marco Sparvieri
IPO DateMay 4, 2012
Employees1,605
CountryMX

Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and i…

what is genomma lab internacional, s.a.b. de c.v. · gnmlf stock overview · genomma lab internacional, s.a.b. de c.v. company profile · who is genomma lab internacional, s.a.b. de c.v. ceo · gnmlf OTC · genomma lab internacional, s.a.b. de c.v. headquarters · genomma lab internacional, s.a.b. de c.v. business segments

About Stock Overview & Key Data

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since May 4, 2012. As of the latest trading session, GNMLF stock price is $0.95, with a market capitalization of $928.9M. The stock has returned -16.67% over the past 12 months and -10.38% year-to-date.

In fiscal year 2025, Genomma Lab Internacional, S.A.B. de C.V. reported revenue of $17.5B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) stock price is $0.95. The stock is traded on OTC under the ticker symbol GNMLF. The 52-week range is $0.91 – $1.17.

GNMLF stock priceGNMLF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice